Carmustine (Administration)
Carmustine is administered intravenously, usually in a hospital setting. The dosage and schedule of administration vary depending on the specific cancer being treated and the patient’s individual needs.
Mechanism of action
Carmustine works by damaging the DNA of cancer cells, preventing them from dividing and growing. It is an alkylating agent, which means it attaches an alkyl group to the DNA molecule, causing damage and cell death.